Cullinan Oncology, Inc. (CGEM)

NASDAQ: CGEM · IEX Real-Time Price · USD
17.04
-0.69 (-3.89%)
At close: Mar 28, 2024, 4:00 PM
17.35
+0.31 (1.82%)
After-hours: Mar 28, 2024, 4:21 PM EDT

Total Valuation

CGEM has a market cap or net worth of $763.55 million. The enterprise value is $300.08 million.

Market Cap 763.55M
Enterprise Value 300.08M

Important Dates

The last earnings date was Thursday, March 14, 2024, before market open.

Earnings Date Mar 14, 2024
Ex-Dividend Date n/a

Share Statistics

CGEM has 43.07 million shares outstanding. The number of shares has decreased by -10.91% in one year.

Shares Outstanding 43.07M
Shares Change (YoY) -10.91%
Shares Change (QoQ) +0.18%
Owned by Insiders (%) 7.15%
Owned by Institutions (%) 94.74%
Float 25.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.68
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 17.07, with a Debt / Equity ratio of 0.01.

Current Ratio 17.07
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -32.10% and return on invested capital (ROIC) is -41.79%.

Return on Equity (ROE) -32.10%
Return on Assets (ROA) -30.40%
Return on Capital (ROIC) -41.79%
Revenue Per Employee n/a
Profits Per Employee -$1.80M
Employee Count 85
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -14.12M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +62.60% in the last 52 weeks. The beta is 0.34, so CGEM's price volatility has been lower than the market average.

Beta (1Y) 0.34
52-Week Price Change +62.60%
50-Day Moving Average 16.53
200-Day Moving Average 11.57
Relative Strength Index (RSI) 52.96
Average Volume (30 Days) 425,070

Short Selling Information

The latest short interest is 935,407, so 2.17% of the outstanding shares have been sold short.

Short Interest 935,407
Short Previous Month 694,101
Short % of Shares Out 2.17%
Short % of Float 3.62%
Short Ratio (days to cover) 1.27

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -191.09M
Pretax Income -167.28M
Net Income -153.16M
EBITDA -166.97M
EBIT -167.28M
Earnings Per Share (EPS) -$3.69
Full Income Statement

Balance Sheet

The company has $467.07 million in cash and $3.59 million in debt, giving a net cash position of $463.48 million or $10.76 per share.

Cash & Cash Equivalents 467.07M
Total Debt 3.59M
Net Cash 463.48M
Net Cash Per Share $10.76
Equity / Book Value 453.70M
Book Value Per Share 10.54
Working Capital 452.05M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$134.28 million and capital expenditures -$208,000, giving a free cash flow of -$134.48 million.

Operating Cash Flow -134.28M
Capital Expenditures -208,000
Free Cash Flow -134.48M
FCF Per Share -$3.24
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 10.91%
Shareholder Yield 10.91%
Earnings Yield -20.06%
FCF Yield -17.61%

Analyst Forecast

The average price target for CGEM is $28.67, which is 68.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target $28.67
Price Target Difference 68.25%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3